Pharmaceutical

Novo Holdings acquires biopharma company Paratek for $462m

Novo Holdings has acquired Paratek Pharmaceuticals for nearly $462m to bolster its antimicrobial resistance (AMR) expertise.

Sep 23, 2023 - 20:00
Novo Holdings acquires biopharma company Paratek for $462m
Novo Holdings has acquired Paratek Pharmaceuticals for nearly $462m to bolster its antimicrobial resistance (AMR) expertise.
Read the original article

Tags:

Previous Article

Yale and Transcend wins US DoD grant for PTSD therapy

Next Article

Glenmark Pharma to divest 75% stake in life sciences unit for $680m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Snap Spanish elections throw health reimbursement reform into doubt

Snap Spanish elections throw health reimbursement refor...

Jun 13, 2023

Opinion: Doctors need to pay more attention to non-physical side effects of health care

Opinion: Doctors need to pay more attention to non-phys...

Aug 7, 2023

STAT+: KRAS, the ideal cancer drug target that became ‘undruggable,’ takes on a new glow

STAT+: KRAS, the ideal cancer drug target that became ‘...

Aug 31, 2023